[go: up one dir, main page]

ES2007720A6 - Procedimiento de obtencion de una vacuna a base de flagelo bacterial. - Google Patents

Procedimiento de obtencion de una vacuna a base de flagelo bacterial.

Info

Publication number
ES2007720A6
ES2007720A6 ES8702709A ES8702709A ES2007720A6 ES 2007720 A6 ES2007720 A6 ES 2007720A6 ES 8702709 A ES8702709 A ES 8702709A ES 8702709 A ES8702709 A ES 8702709A ES 2007720 A6 ES2007720 A6 ES 2007720A6
Authority
ES
Spain
Prior art keywords
flagel
bacterial
procedure
obtaining
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8702709A
Other languages
English (en)
Inventor
Robert L Hunter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Publication of ES2007720A6 publication Critical patent/ES2007720A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE UNA VACUNA A BASE DE FLAGELO BACTERIAL, CARACTERIZADO PORQUE COMPRENDE: A) AISLAR FLAGELO DE UNA BACTERIA FLAGELADA PORAPLICACION DE UN ESFUERZO CORTANTE PARA ROMPER EL FLAGELO DE SUSCUERPOS CELULARES Y SEPARACION DEL FLAGELO DE LOS CUERPOS CELULARES POR CENTRIFUGADO; Y B) CONJUGAR QUIMICAMENTE DICHO FLAGELO A UN ANTIGENO, CON UN COMPUESTO RETICULANTE QUIMICO. LA VACUNA ES ESPECIALMENTE EFICAZ PARA VACUNAR UN HUMANO O UN ANIMAL CONTRA UN PEPTIDO U OTRO PEQUEÑO HAPTENO. LA VACUNA MEJORADA PROPORCIONA UNA INMUNO-RESPUESTA PROLONGADA Y POTENTE CONTRA EL PEPTIDO U OTRO PEQUEÑO HAPTENO.
ES8702709A 1986-09-22 1987-09-22 Procedimiento de obtencion de una vacuna a base de flagelo bacterial. Expired ES2007720A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90996486A 1986-09-22 1986-09-22
US7518787A 1987-07-16 1987-07-16

Publications (1)

Publication Number Publication Date
ES2007720A6 true ES2007720A6 (es) 1989-07-01

Family

ID=26756538

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8702709A Expired ES2007720A6 (es) 1986-09-22 1987-09-22 Procedimiento de obtencion de una vacuna a base de flagelo bacterial.

Country Status (17)

Country Link
EP (1) EP0283505B1 (es)
JP (1) JPH01501064A (es)
KR (1) KR920002165B1 (es)
CN (1) CN1030019A (es)
AP (1) AP8700068A0 (es)
AT (1) ATE108067T1 (es)
BR (1) BR8707471A (es)
CA (1) CA1322721C (es)
DE (1) DE3750176T2 (es)
DK (1) DK272688A (es)
ES (1) ES2007720A6 (es)
FI (1) FI882397A0 (es)
GR (1) GR871460B (es)
IL (1) IL83953A (es)
NZ (2) NZ236829A (es)
PT (1) PT85760B (es)
WO (1) WO1988001873A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3889521T2 (de) * 1987-11-03 1994-12-08 Syntex (U.S.A.) Inc., Palo Alto, Calif. Impfstoff-Adjuvans.
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
WO2001085208A2 (en) 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
KR20020032772A (ko) * 2000-10-27 2002-05-04 김정우 살모넬라균에 대한 난황항체
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
KR100489615B1 (ko) * 2002-01-30 2005-05-17 주식회사 단바이오텍 리스테리아 모노사이토제네스 감염의 예방 및 치료를 위한항체, 이를 포함하는 알 및 이들의 제조방법
NZ538083A (en) 2002-07-17 2006-08-31 Cytos Biotechnology Ag Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
CA2487849A1 (en) 2002-07-18 2004-01-29 Cytos Biotechnology Ag Hapten-carrier conjugates comprising virus like particles and uses thereof
NZ537688A (en) 2002-07-19 2007-01-26 Cytos Biotechnology Ag Vaccine compositions containing amyloid beta1-6 antigen arrays for treating and/or attenuating Alzheimer's disease
US20060257415A1 (en) * 2002-09-03 2006-11-16 Fondation Eurov Acc Adjuvants
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
ES2555544T3 (es) 2006-03-07 2016-01-04 Vaxinnate Corporation Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas
BRPI0905729A2 (pt) * 2008-01-18 2015-07-14 Aeras Global Tb Vaccine Found "polipeptídeo antigênico recombinante, peptídeo antigênico recombinante, ácido nucléico e método para imunizar um indivíduo contra malária"
CN104080475A (zh) 2008-04-18 2014-10-01 法克斯因内特公司 鞭毛蛋白的缺失突变体以及使用方法
US20120171239A1 (en) * 2009-09-03 2012-07-05 Mizel Steven B Immunogenic Conjugates for Producing Immune Responses to Drugs of Abuse and Methods of Use
CN101914144B (zh) * 2010-04-30 2013-01-09 浙江大学 金黄色葡萄球菌荚膜多糖和蛋白质偶联物及制备方法和用途
CN102580081B (zh) * 2012-02-22 2014-07-02 中国医学科学院医学生物学研究所 Nad、氢氧化铝复合佐剂及含该复合佐剂的疫苗
US8932598B2 (en) 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2979528A (en) * 1953-10-19 1961-04-11 Wyandotte Chemicals Corp Nitrogen-containing polyoxyalkylene detergent compositions
US2674619A (en) * 1953-10-19 1954-04-06 Wyandotte Chemicals Corp Polyoxyalkylene compounds
US3022335A (en) * 1955-03-30 1962-02-20 Wyandotte Chemicals Corp Surface active polyoxyalkylene compounds having a plurality of heteric polyoxypropylene-polyoxyethylene chains
US3036118A (en) * 1957-09-11 1962-05-22 Wyandotte Chemicals Corp Mixtures of novel conjugated polyoxyethylene-polyoxypropylene compounds
WO1979000160A1 (en) * 1977-09-28 1979-04-05 Nat Res Dev Improvements in or relating to immunological preparations
WO1980001986A1 (en) * 1979-03-27 1980-10-02 A Sanderson Improvements in or relating to immunological preparations
US4372945A (en) * 1979-11-13 1983-02-08 Likhite Vilas V Antigen compounds
FR2517967A1 (fr) * 1981-12-10 1983-06-17 Air Liquide Procede de production d'un vaccin biochimique contre les fievres a salmonelles
US4711876A (en) * 1985-12-05 1987-12-08 Catapano Salvatore J Process for the treatment and remission of AIDS (acquired immune deficiency syndrome)

Also Published As

Publication number Publication date
FI882397L (fi) 1988-05-20
FI882397A7 (fi) 1988-05-20
DK272688A (da) 1988-07-12
ATE108067T1 (de) 1994-07-15
IL83953A0 (en) 1988-02-29
PT85760B (pt) 1990-08-31
WO1988001873A1 (en) 1988-03-24
AU629103B2 (en) 1992-09-24
KR920002165B1 (ko) 1992-03-19
GR871460B (en) 1988-03-21
KR880701560A (ko) 1988-11-03
JPH01501064A (ja) 1989-04-13
NZ221868A (en) 1991-03-26
AU7113191A (en) 1991-07-11
NZ236829A (en) 1993-07-27
BR8707471A (pt) 1988-09-13
FI882397A0 (fi) 1988-05-20
AU8023287A (en) 1988-04-07
CA1322721C (en) 1993-10-05
PT85760A (en) 1987-10-01
DK272688D0 (da) 1988-05-18
EP0283505B1 (en) 1994-07-06
EP0283505A1 (en) 1988-09-28
DE3750176D1 (de) 1994-08-11
AP8700068A0 (en) 1989-03-21
CN1030019A (zh) 1989-01-04
AU613588B2 (en) 1991-08-08
EP0283505A4 (en) 1989-11-07
DE3750176T2 (de) 1994-10-13
IL83953A (en) 1992-05-25

Similar Documents

Publication Publication Date Title
ES2007720A6 (es) Procedimiento de obtencion de una vacuna a base de flagelo bacterial.
ES2091684T3 (es) Aplicacion terapeutica de anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de las celulas b.
ES2129423T3 (es) Vacunas.
ES2054649T3 (es) 2-aminotetralinas basicas substituidas.
ES2055587T3 (es) El uso de agonistas selectivos de gaba-b como agentes antitusivos.
ES2104731T3 (es) Micobacterium utilizado como adyuvante para antigenos.
ES2144051T3 (es) Cebo y trampa.
DK230188D0 (da) Grundlag for slimhinde- og proteseklaebepastaer samt fremstilling og anvendelse heraf
FI873363A0 (fi) Foerfarande foer framstaellning av laekemedel med antitumoeraktivitet.
ES2080256T3 (es) Mezcla esterilizante y metodo de esterilizacion.
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
ES2130121T3 (es) Antigeno intra-acrosomico de esperma humano para uso en una vacuna anticonceptiva.
DK234780A (da) 6beta,7beta,15,16-dimethylen-1,4-androstadien-3-oner fremgangsmaade til fremstilling heraf og anvendelsen heraf som laegemiddel
AU6618986A (en) Immunostimulant agents
IT8921490A0 (it) Procedimento e dispositivo per la fabbricazione di lattine mediante stiramento.
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ES2079438T5 (es) Lubricante esterilizable.
IT8447630A0 (it) Dispositivo medico per la riparazione senza sutura di nervi lacerati, recisi o innestati e procedimentodi preparazione
AR009604A1 (es) Procedimiento para la separacion de clna de una solucion de cili
ES2038969T3 (es) Procedimiento para la renaturalizacion de proteinas.
NO893288D0 (no) Fremgangsmaate for fremstilling av et nytt antibiotikum, mersacidin, og anvendelse derav som legemiddel.
ES2088431T3 (es) Preparacion biologica y su utilizacion.
ES2106032T3 (es) Vacuna para inmunizar gatos contra el desprendimiento de oocistos de toxoplasma.
ES2059305T5 (es) Proteina del virus de la seudorrabia.

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2007-09-22

FD1A Patent lapsed

Effective date: 20001204